Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Multicenter Phase II Safety and Preliminary Efficacy Study of 2 Dose Regimens of HepaStem in Patients With Acute on Chronic Liver Failure
Brief Summary: The study will assess the safety of two dose regimens of HepaStem in Patients with ACLF up to Day 28 of the active study period.